Viewing Study NCT05972135


Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2025-12-25 @ 8:08 PM
Study NCT ID: NCT05972135
Status: RECRUITING
Last Update Posted: 2025-10-29
First Post: 2023-07-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Sponsor: SCRI Development Innovations, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module